Key Highlights

  • TuHURA Biosciences accessed a further $650,000 from its $50 million revolving Credit facility.
  • The Facility is provided by Parkview Holdings.
  • The draw secures Debt Capital for operational needs.
  • The company continues to manage significant cash burn and a lack of Revenue alongside growing net losses.

TuHURA Biosciences, Inc. (NASDAQ: HURA) accessed a further $650,000 from its $50 million revolving credit facility provided by Parkview Holdings, securing debt capital for operational needs.

What Happened

The draw comes even as the company manages significant cash burn and a lack of revenue alongside growing net losses.

Market Reaction

The disclosed information does not include stock price or trading data for TuHURA Biosciences following the credit facility draw.

Outlook

Continued reliance on the $50 million Parkview Holdings revolving credit facility is likely to remain relevant for TuHURA Biosciences' operational funding needs, given the company's ongoing cash burn and lack of revenue.